AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
14 Nov 2002 03:00 PM
RNS
Directorate Change
14 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
11 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
07 Nov 2002 08:30 AM
RNS
Annual Review
07 Nov 2002 07:00 AM
RNS
Crestor
05 Nov 2002 01:00 PM
RNS
Omeprazole Judgment Appeal
28 Oct 2002 07:00 AM
RNS
Exanta Express
24 Oct 2002 11:00 AM
RNS
3rd Quarter Results-Part 2
24 Oct 2002 11:00 AM
RNS
3rd Quarter Results-Part 1
23 Oct 2002 09:00 AM
RNS
Notice of Results
22 Oct 2002 11:49 AM
RNS
Omeprazole Patent Ruling
14 Oct 2002 07:06 AM
RNS
Prilosec Patents Ruling
30 Sep 2002 04:00 PM
RNS
Holding(s) in Company
25 Sep 2002 07:01 AM
RNS
Iressa
16 Sep 2002 07:00 AM
RNS
Symbicort
12 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
11 Sep 2002 03:00 PM
RNS
Capital Group
11 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
10 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
06 Sep 2002 07:00 AM
RNS
Arimidex
06 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
05 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
04 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
02 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
02 Sep 2002 07:00 AM
RNS
Crestor Data
30 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
22 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
21 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
19 Aug 2002 11:30 AM
RNS
Iressa Announcement
15 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
14 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
12 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
09 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
08 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
07 Aug 2002 01:00 PM
RNS
Iressa
06 Aug 2002 02:00 PM
RNS
Update on Crestor
25 Jul 2002 11:00 AM
RNS
Interim Results - Part 2
25 Jul 2002 11:00 AM
RNS
Interim Results - Part 1
24 Jul 2002 09:00 AM
RNS
Notice of Results
05 Jul 2002 07:13 AM
RNS
Iressa In Japan
28 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
27 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
26 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
25 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
24 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
21 Jun 2002 07:00 AM
RNS
Research Update
17 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
14 Jun 2002 07:00 AM
RNS
Purchase of Own Securities

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings